Natco Pharma Ltd
NSE:NATCOPHARM
Natco Pharma Ltd
NSE:NATCOPHARM
Price:
798.75
INR
-2.92%
Market Closed
Market Cap:
143.1B
INR
Cash Flow Statement
Cash Flow Statement
Natco Pharma Ltd
Natco Pharma Ltd
Currency: INR
Millions
TTM
| Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||
| Net Income |
5 687
|
6 743
|
5 796
|
3 116
|
2 022
|
4 975
|
8 619
|
13 454
|
16 735
|
23 557
|
|
| Depreciation & Amortization |
998
|
1 126
|
1 169
|
1 287
|
1 426
|
1 554
|
1 638
|
1 696
|
1 868
|
1 896
|
|
| Other Non-Cash Items |
(458)
|
(313)
|
(548)
|
(662)
|
(187)
|
(186)
|
(618)
|
(557)
|
(530)
|
(1 095)
|
|
| Cash Taxes Paid |
1 078
|
867
|
1 300
|
849
|
482
|
1 226
|
1 775
|
2 095
|
2 863
|
3 550
|
|
| Cash Interest Paid |
221
|
154
|
128
|
124
|
170
|
188
|
142
|
146
|
181
|
190
|
|
| Change in Working Capital |
(2 054)
|
(3 090)
|
(3 429)
|
(3 511)
|
(2 796)
|
1 959
|
(1 148)
|
(7 117)
|
(5 957)
|
(7 195)
|
|
| Cash from Operating Activities |
4 173
N/A
|
4 466
+7%
|
2 988
-33%
|
230
-92%
|
465
+102%
|
8 302
+1 685%
|
8 491
+2%
|
7 476
-12%
|
12 116
+62%
|
17 163
+42%
|
|
| Investing Cash Flow | |||||||||||
| Capital Expenditures |
(3 586)
|
(2 912)
|
(2 546)
|
(2 710)
|
(2 328)
|
(2 113)
|
(2 056)
|
(2 169)
|
(3 587)
|
(4 325)
|
|
| Other Items |
1 916
|
843
|
1 513
|
3 176
|
2 275
|
(1 929)
|
(2 715)
|
(2 608)
|
(6 740)
|
(11 341)
|
|
| Cash from Investing Activities |
(1 670)
N/A
|
(2 069)
-24%
|
(1 033)
+50%
|
466
N/A
|
(53)
N/A
|
(4 042)
-7 526%
|
(4 771)
-18%
|
(4 777)
0%
|
(10 327)
-116%
|
(15 666)
-52%
|
|
| Financing Cash Flow | |||||||||||
| Net Issuance of Common Stock |
(535)
|
3
|
1
|
1
|
0
|
0
|
(74)
|
(2 611)
|
(2 537)
|
77
|
|
| Net Issuance of Debt |
(809)
|
1 170
|
(496)
|
(698)
|
1 358
|
(2 805)
|
(2 410)
|
1 555
|
1 957
|
(412)
|
|
| Cash Paid for Dividends |
(1 536)
|
(1 401)
|
(1 139)
|
(1 092)
|
(822)
|
(1 097)
|
(1 004)
|
(1 620)
|
(1 708)
|
(991)
|
|
| Other |
372
|
(23)
|
(223)
|
(252)
|
(188)
|
(188)
|
(142)
|
(146)
|
(181)
|
(190)
|
|
| Cash from Financing Activities |
(2 508)
N/A
|
(251)
+90%
|
(1 857)
-640%
|
(2 041)
-10%
|
348
N/A
|
(4 090)
N/A
|
(3 630)
+11%
|
(2 822)
+22%
|
(2 469)
+13%
|
(1 516)
+39%
|
|
| Change in Cash | |||||||||||
| Effect of Foreign Exchange Rates |
(80)
|
(232)
|
(38)
|
(19)
|
93
|
213
|
118
|
82
|
65
|
25
|
|
| Net Change in Cash |
(85)
N/A
|
1 914
N/A
|
60
-97%
|
(1 364)
N/A
|
853
N/A
|
383
-55%
|
208
-46%
|
(41)
N/A
|
(615)
-1 400%
|
6
N/A
|
|
| Free Cash Flow | |||||||||||
| Free Cash Flow |
587
N/A
|
1 554
+165%
|
442
-72%
|
(2 480)
N/A
|
(1 863)
+25%
|
6 189
N/A
|
6 435
+4%
|
5 307
-18%
|
8 529
+61%
|
12 838
+51%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
